References
- Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics 2000;106:E27. https://doi.org/10.1542/peds.106.2.e27
- Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44. https://doi.org/10.1016/S0140-6736(04)16814-1
- Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85. https://doi.org/10.1161/01.CIR.94.6.1379
- Suda K, Kudo Y, Higaki T, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J 2009;73: 1319-23. https://doi.org/10.1253/circj.CJ-08-0931
- Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79-85. https://doi.org/10.2188/jea.JE20110131
- McNeal-Davidson A, Fournier A, Scuccimarri R, et al. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976. Pediatr Cardiol 2013;34:170-8. https://doi.org/10.1007/s00246-012-0409-2
- Suzuki N, Seguchi M, Kouno C, Inukai K, Kito H, Kobayashi H. Rupture of coronary aneurysm in Kawasaki disease. Pediatr Int 1999;41:318-20. https://doi.org/10.1046/j.1442-200x.1999.01058.x
- Imai Y, Sunagawa K, Ayusawa M, et al. A fatal case of ruptured giant coronary artery aneurysm. Eur J Pediatr 2006;165:130-3. https://doi.org/10.1007/s00431-005-0016-9
- Panzer J, De Jaeger A, Suys B. Rupture of giant coronary arterial aneurysm without progressive dilation. Cardiol Young 2008;18:189-90.
- Sunagawa K, Mitsumata M, Ayusawa M, Kusumi Y. Ruptured giant aneurysm of the left anterior descending coronary artery in Kawasaki disease. Pediatr Cardiol 2008;29:1115-9. https://doi.org/10.1007/s00246-008-9236-x
- Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 2000;42:470-5. https://doi.org/10.1046/j.1442-200x.2000.01270.x
- Ohkubo T, Fukazawa R, Ikegami E, Ogawa S. Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations. Pediatr Int 2007;49:1-7. https://doi.org/10.1111/j.1442-200X.2007.02312.x
- Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn 1991;33:27-35. https://doi.org/10.1111/j.1442-200X.1991.tb01516.x
- Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979;63:175-9.
- Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 2012;379:1613-20. https://doi.org/10.1016/S0140-6736(11)61930-2
- Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 2013;99:76-82. https://doi.org/10.1136/heartjnl-2012-302126
- Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43:211-7. https://doi.org/10.1046/j.1442-200x.2001.01373.x
Cited by
- Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children vol.28, pp.3, 2014, https://doi.org/10.1017/s1047951117001470
- Relapse of nephrotic syndrome triggered by Kawasaki disease vol.7, pp.1, 2014, https://doi.org/10.1007/s13730-017-0282-1
- Lymph-node-first Kawasaki disease and giant coronary artery aneurysm vol.12, pp.2, 2019, https://doi.org/10.1136/bcr-2018-226897